Filing Details

Accession Number:
0001209191-20-031059
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-20 20:02:28
Reporting Period:
2020-05-18
Accepted Time:
2020-05-20 20:02:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1631320 Jr. Donald Michael Abney 9975 Summers Ridge Road
San Diego CA 92121
Svp - Distribution No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-18 8,798 $15.40 15,432 No 4 M Direct
Common Stock Disposition 2020-05-18 8,798 $198.12 6,634 No 4 S Direct
Common Stock Acquisiton 2020-05-18 7,172 $21.08 13,806 No 4 M Direct
Common Stock Disposition 2020-05-18 7,172 $198.87 6,634 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option Disposition 2020-05-18 8,798 $0.00 8,798 $15.40
Common Stock Non-Qualified Stock Option Disposition 2020-05-18 7,172 $0.00 7,172 $21.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-02-10 No 4 M Direct
7,171 2027-02-15 No 4 M Direct
Footnotes
  1. The weighted average sale price for these transactions was $198.1224 per share, with a range of $193.13 to $201.97. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
  2. The weighted average sale price for these transactions was $198.8715 per share, with a range of $196.035 to $201.97. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
  3. 17,596 shares vested on the second anniversary date of the grant date, February 10, 2018. 8.798 shares vested on the third anniversary date of the grant date, February 10, 2019. 8,798 shares vested on the fourth anniversary date of the grant date, February 10, 2020.
  4. 7,172 shares vested on the second anniversary date of the grant date, February 15, 2019. 3,586 shares vested on the third anniversary date of the grant date, February 15, 2020. 3,585 shares will vest on the fourth anniversary date of the grant date, February 15, 2021.